of CFC produced per LTC-IC varied from 1 to 13. Surprisingly, in each case the concentration of cytogenetically normal factor (SF), and flt-3 ligand (FL) on acute myelogenous leukemia (AML) blasts using the short-term endpoints of prolifera-LTC-IC detected in AML patient blood was at least 10-fold higher than that previously observed in the blood of normal tion in 
T gous progenitor types among the malignant cells of patients with AML. Previous efforts to characterize primitive AML HE TERM ACUTE myelogenous leukemia (AML) encompasses a group of disorders characterized by the presence of malignant clones of hematopoietic cells exhibprogenitors in this system had suggested that they were poorly maintained under standard LTC conditions. 15 Howiting varying degrees of terminal differentiation. 1 The facts that individual AML blasts commonly express cell surface ever, in the intervening years several modifications that improve detection of normal LTC-IC had been made to the antigens typical of more than one myeloid lineage and that cells of the erythroid, megakaryocytic, and granulocytic linsystem that suggested that a reinvestigation of this approach was warranted. Firstly, the discovery that preestablished eages are part of the malignant clone in some patients with AML 2-4 suggest that the transforming event in these leukefeeder layers from a variety of species and tissue sources can substitute for endogenous marrow stromal cells 16 as supmias occurs in a primitive progenitor with multilineage differentiative potential. A subpopulation of the malignant cells port for long-term human hematopoiesis has not only allowed the standardization of LTC conditions, but it has also from patients with AML gives rise to colonies of terminally differentiated blasts when plated in semisolid medium suppermitted the LTC-IC content of any cell source to be determined, including those incapable of generating stromal supplemented with hematopoietic growth factors (AML-CFC) 5 and in liquid suspension culture some expansion of this popport such as peripheral blood (PB) cells or highly purified populations of progenitor cells. 10, 13, 17, 18 In addition, by engiulation can be achieved. [6] [7] [8] Recently it has also been possible to physically separate AML cells with different proliferative neering murine stromal cell lines to constitutively produce capacities in long-term suspension culture based on their cell surface phenotype. 9 Taken together, these findings support
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factor (GM-CSF; Sandoz), granulocyte-CSF (G-CSF; Amgen, Thou- human cytokines to which normal LTC-IC were known to sand Oaks, CA), IL-6 (Terry Fox Laboratory, Vancouver, Canada), be responsive, it has been possible to enhance the sensitivity IL-11 (Genetics Institute, Cambridge, MA), or IL-1b (Biogen, Camof detection of these progenitors and their output of CFC bridge, MA); and 100 ng/mL of Steel factor (SF; purified in our progeny. 19 It therefore seemed possible that such feeders center from supernatants of COS cells transfected with the cytokine might also facilitate detection of a putative analogous leukecDNA), IL-2 (Biotest Pharma, Dreieich, Germany), or flt-3 ligand mic progenitor population from patients with AML. Sec-(FL; Immunex, Seattle, WA). After incubation for 3 days at 37ЊC, ondly, many hematopoietic growth factors that have activity 1 mCi of 3 H-Tdr was added to each well. After 6 hours of additional on primitive normal progenitors and enhance their detection incubation, cells were obtained dried onto a glass fiber filter using in colony assays also stimulate both unfractionated AML an LKB Betaplate cell harvester (Wallac, Turku, Finland), and 3 HTdr incorporation counted in a LKB Betaplate liquid scintillation blasts and AML-CFC. 20 , 21 The use of such recombinant cytocounter (Wallac). All assays were set up in triplicate and the results kines might then also be expected to improve the detection expressed as the mean { SEM cpm of the three replicate cultures.
of CFC produced by malignant LTC-IC. Finally, fluorescent were first tested in short-term proliferation studies and col-
The results of the short-term assays described above and experience ony assays. Using both this information and our experience from previous efforts to optimize LTC conditions for detection of in optimizing LTC for detecting normal LTC-IC, LTC expernormal LTC-IC 19 were used to design the LTC conditions to be iments were designed with a series of AML patient samtested for their ability to support primitive AML cells (Table 2) .
ples. 19 Despite the anticipated heterogeneity among different
Human marrow feeders (HMF) were selected because they were the AML samples in both short-term and long-term cultures, our feeders used in the original description of the LTC-IC assay, 10 and results show that malignant progenitors that initiate LTC Sl/Sl mouse fibroblast feeders were chosen because they had been shown to provide support equivalent to HMF for normal LTC-IC (AML LTC-IC) can be routinely detected and both their maintenance and differentiation. 23 Sl/Sl feeders had also been transfrequency and proliferative capacity measured using limiting fected with the human IL-3 and SF genes to derive two of the dilution analysis techniques. Manipulation of the growth engineered feeders tested in this study and thus they also served as conditions in the LTC assay have allowed some interesting controls for assessing the effects of these growth factors in LTC.
differences between the responses of normal and leukemic
The mixed feeders producing IL-3, G-CSF, and SF were chosen progenitors to be revealed.
because of their demonstrated ability to enhance the detection of and CFC output from normal LTC-IC. 19 The three growth conditions MATERIALS AND METHODS using Sl/Sl feeders and one or more of the growth factors IL-3, SF, and FL were selected to supplement LTC with cytokines which were Patient cells. PB or bone marrow (BM) cells were obtained from found to be most active on AML cells in short-term assays. The patients with newly diagnosed AML undergoing marrow and blood addition of FL supplements to mixed growth factor-producing feedexamination for diagnostic purposes after informed consent. Monoers was included in an effort to maximize stimulation of primitive nuclear cells were separated by Ficoll-Hypaque (Pharmacia, Upp-AML progenitors based on evidence that this cytokine has potent sala, Sweden) density gradient centrifugation and either used immeeffects on normal LTC-IC.
24 diately for the experiments described below or cryopreserved in Long-term cultures. HMF were obtained as previously de-DMEM with 50% fetal calf serum (FCS) and 10% dimethylsulfoxscribed 25 by subculturing cells from 2-to 6-week-old confluent noride. As part of their clinical evaluation all patient samples had mormal BM adherent layers established in primary LTC. These were phological, histochemical, and flow cytometric studies performed on trypsinized and irradiated with 15 Gy of 250 kilovolt (peak) x-rays their leukemic blasts with subsequent classification according to and then seeded into new tissue culture dishes at 3 1 10 4 cells/cm 2 . French-American-British subtypes.
1 Cytogenetic analysis was perSl/Sl feeders consist of Sl/Sl fibroblasts originally obtained from formed on the initial diagnostic BM sample. Baseline clinical and Sl/Sl mouse embryos. 23 Sl/Sl-J-IL-3 fibroblasts were obtained by laboratory data on the patients whose cells were evaluated extentransduction of Sl/Sl fibroblasts with a human IL-3 cDNA-containing sively in this study are shown in Table 1 . Nine of these samples retrovirus as previously described. 19 These cells produce bioactive were tested under a variety of different growth conditions in LTC.
human Abbreviation: RAEBIT, refractory anemia with excess blasts in transformation. * WBC, peripheral blood total white blood cell count at diagnosis. † Probes used are described in detail in Materials and Methods.
pended in Myelocult LTC media (StemCell) with 10 06 mol/L solusuch a microwell plate is thus a ''mini LTC.'' After 5 weeks of cortef (Sigma-Aldrich Canada Ltd, Oakville, Ontario, Canada) and culture all nonadherent and adherent cells from each well were harseeded onto the various feeders at different cell concentrations as vested and plated in methylcellulose assays containing 3 U/mL Epo, required by the experimental design. Cultures were maintained at 10 ng/mL GM-CSF, 10 ng/mL IL-3, 50 ng/mL SF, and 50 ng/mL 37ЊC in 5% CO 2 and received weekly one-half-media changes. In FL. The frequency of LTC-IC in the starting cell population and the LTCs, which were supplemented with SF or FL, the weekly halfaverage number of CFC generated per LTC-IC were calculated from medium change contained the cytokine of interest at twice the final the frequency of negative wells (wells containing no detectable CFC) concentration (50 ng/mL). In addition, a second dose of the cytokine in each group and the total number of CFC in the positive wells as was added midweek between feedings to yield the same final concenpreviously described. 10 tration. After 5 weeks both nonadherent and adherent cells were FISH. Individual colonies were plucked from methylcellulose obtained from LTC (the latter by trypsinization), 16 pooled, and plated assays using finely drawn glass pipets into hypotonic (0.075 mol/L) in methylcellulose as described above (supplemented with 3 U/mL KCl and fixed in methanol to acetic acid (3:1) on multiwell glass Epo, 10 ng/mL GM-CSF, 10 ng/mL IL-3, and 50 ng/mL SF) to slides (Celline Assoc, New Field, NJ). Although some attempts were determine the clonogenic cell content of each LTC.
made to synchronize colony cells in metaphase as previously deFor limiting dilution analyses, light density AML cells were plated scribed, 28 DNA probes were selected to recognize karyotypic abnorat four cell concentrations, ranging from 10 4 to 5 1 10 5 cells per malities in the leukemic cells in interphase (Table 1) polymerase chain reaction (PCR) using primers and PCR conditions
Sl/Sl JIL-3 (IL-3, 16.5 ng/mL) FL (50 ng/mL) described elsewhere. 29 The PCR product was then labeled with specMixed (IL-3, 2.5 ng/mL; G-CSF, 95 ng/ -trum green by nick translation. The 11q23 MLL probe labeled with mL; SF, 2 ng/mL) DIG was purchased from Oncor (Gaithersburg, MD). In the case
Mixed (IL-3, 2.5 ng/mL; G-CSF, 95 ng/ FL (50 ng/mL) of patients 1 and 2 with the 0Y abnormality (Table 1) , a double mL; SF, 2 ng/mL) hybridization was done with biotin-labeled pRY3.4 and DIG-labeled D8Z2, the latter serving as an internal control to ensure, in the * Soluble cytokines were added twice weekly to achieve final conabsence of a Y signal, that the FISH procedure had been successful. mg/mL salmon sperm DNA, were denatured at 75ЊC for 5 minutes powder) followed by four 5-minute washes, three at RT in PN buffer * Cytokines tested at final concentrations of 40 ng/mL for IL-3, GMand one in 41 SSC with 0.1% Triton X-100 at 40ЊC. Biotin-labeled CSF, G-CSF, IL-6, IL-11, and IL-1 and 100 ng/mL for SF, IL-2, and FL.
probes were detected by incubation of the slide for 45 minutes at † As compared with control cultures without cytokines.
37ЊC with 25 mg/mL avidin-Texas Red (TR; Vector Labs) in 41 SSC, 1% BSA followed by 10-minute RT washes in 41 SSC, 41 SSC with 0.1% Triton X-100, and PN buffer. Ten micrograms per milliliter of biotin-anti-avidin (Vector Labs) in PNM was then added mamide, 14% wt/vol dextran sulphate, 31 SSC, 40 mg/mL human Cot-1 DNA (BRL). The probe was denatured at 75ЊC for 5 minutes, for 1 hour at 37ЊC followed by three 5-minute RT washes in PN buffer. After a second incubation with avidin-TR, slides were again then incubated at 37ЊC for 30 minutes to allow annealing of repetitive DNA sequences before application to the slides. Denatured probes washed three times in PN and finally in 41 SSC with 0.1% Triton X-100 at 40ЊC. Slides were counterstained either with 0.5 mg/mL were applied to slides that were then coverslipped, sealed with rubber For 
Abbreviation: ND, not determined. terphase cells ( Table 1 ). As shown in Table 4 kine cocktail further increased the number of colonies de-
RESULTS
rived from 14 (28%) of these 50 samples. Interestingly, among the 19 AML samples tested in methylcellulose assay Cytokine responsiveness of AML cells in short-term containing serum but no other source of cytokines, 9 showed assays. In preliminary experiments nine different cytokines evidence of factor-independent colony growth. However, were tested alone and in combination for their ability to five of these also showed increased colony formation when stimulate 3 H-Tdr incorporation into AML blasts after 3 days cytokines were added. Table 5 shows the results of methylin liquid suspension culture (Table 3 ). There was great hetcellulose colony assays with or without the addition of reerogeneity both in the baseline proliferative activity in the combinant cytokines from the 10 patient samples selected absence of growth factors and in the extent to which this for further analysis. In general, the growth of AML-CFC proliferation could be enhanced (up to 253-fold). Neverthefrom these samples was similar to that observed in the larger less, for the 53 different patient samples analyzed, evidence group of 50 AML specimens. Some evidence of factor-indeof a significant response to the single factors IL-3, SF, or pendent growth was noted in six cases, but evidence of in-FL was evident in more than 60%, and more than 90% creased colony formation in the presence of one or more responded to two or three of these factors in combination.
cytokines was also obtained with every sample except that The magnitude of the response was also greater with the from patient 6, whose cells also showed a poor response to cytokine combinations (median fold increase 3 H-Tdr incorporation 2-to 4-fold for the cytokines individually versus growth factors as measured by 3 H-Tdr incorporation.
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From the total numbers of CFC detected or the proportion that was (Table 1) were cocultured with irradiated HMF or limiting dilution. To determine the frequency of progeniSl/Sl fibroblasts for 5 weeks with weekly half medium tors initiating LTC among AML PB cells and the average changes. As shown in Table 6 , FISH analysis of colonies number of CFC produced per LTC-IC, cocultures of AML plucked from methylcellulose assays from these 5-week-old cells from six different patients were established at decreas-LTC showed that, in every case, cytogenetically abnormal ing dilutions on HMF feeders. As shown on Table 7 , the colonies could be detected. In colony assays from HMF frequency of LTC-IC calculated from the results of these cocultures, the proportion of CFC carrying the chromosomal experiments varied greatly from as low as 3 to greater than marker was similar to that seen in colonies derived from the 100 per 10 6 cells originally placed in LTC. In every case same cell sample plated directly into methylcellulose, except this frequency was considerably lower than the frequency for patient 7 in whom only CFC that were karyotypically of AML-CFC in the same sample. The mean ({SD) number normal by FISH for trisomy 8 were seen in assays from of CFC produced per LTC-IC in cultures containing HMF HMF cocultures. However, colonies carrying the /8 abnormality were recovered from 5-week-old cocultures of this was 2.1 ({1.1), which is lower than the value of 4 to 7 cell density were analyzed by FISH. Eighteen LTC (42%) produced exclusively cytogenetically abnormal CFC, whereas 23 (53%) generated only cytogenetically normal CFC/LTC-IC obtained for normal blood or marrow LTC-IC colonies and 2 (5%) showed a mixture of normal and abnoranalyzed under similar conditions. 18, 19 A proportion of the mal CFC. The number of CFC produced per LTC-IC ranged CFC detected in both direct methylcellulose assays and in from 1 to 7 and 1 to 30 for the cytogenetically abnormal assays of cells from LTC were cytogenetically abnormal by and normal LTC-IC, respectively. FISH for all patient cell samples except number 9. As shown The concentration of cytogenetically normal and abnormal on Table 1 , this patient had a mixture of cytogenetically LTC-IC in AML PB was calculated using data from Tables normal and abnormal cells on initial BM cytogenetic analy-1 and 7 and compared with the concentration of LTC-IC in sis. Although the morphology of colonies detected in the normal steady state blood that we had previously determined direct methylcellulose assays of PB cells or assays from under the same assay conditions. 18 As shown in Table 8 , in each case the concentration of LTC-IC in AML blood, including those with normal cytogenetics, was at least 10- Table 7 . Frequency and Proliferative Capacity of LTC-IC in AML PB fold, and in two cases more than 100-fold higher than that in Table 6 , engineered feeders previously chosen for their with that present in cocultures with HMF. In contrast to Tables 6 and 7 show that AML LTC-IC can supplemented with IL-3 and SF, the numbers of both cytogenetically normal and abnormal CFC increased with all five be routinely detected in the PB and BM of AML patients at diagnosis. Because the assay is linear (Fig 2) it can be used patient samples so that the relative proportions of each did not change, as compared with control cultures with Sl/Sl to quantitate the numbers of such cells in different clinical samples. Although the expected heterogeneity among AML feeders alone. The response to FL supplements of Sl/Sl or mixed feeder cocultures was similar to that seen with IL-3 patient samples was observed in both the frequency and proliferative capacity of these cells, they could be shown to and SF for four patient samples (numbers 5, 7, 8, and 10). However, testing of cells from patient 4 produced a different be a relatively rare cell population as compared with AML-CFC and, in most cases, to give rise to more than one CFC result. Although the total number of CFC produced changed very little among the different culture conditions with Sl/Sl after 5 weeks in LTC. In two cases some malignant LTC-IC were shown to have erythroid potential. One of these feeders, the addition of FL (//0 IL-3) to these cultures significantly reduced the output of cytogenetically abnormal samples was from a patient with myelodysplasia that had transformed to AML. Multilineage differentiative potential CFC from LTC in each of two experiments. This contrasts with the apparent stimulation of AML cells from this patient of the malignant clone in some patients with AML has been described previously as being associated with a ''smoulderby FL in short-term assays (Tables 4 and 5) .
Although erythropoietin was added to both the initial ing'' or ''preleukemic'' phase and occurring more typically in elderly patients. 4 Thus, it appears that the hierarchical methylcellulose assays of AML cells and the assays from 5-week-old LTC, few erythroid colonies were seen and their nature of blood cell development has been retained among the malignant cells in AML and that the usual target for proportion of the total CFC output did not change significantly under the different culture conditions. Those BFU-E transformation in these diseases is at or upstream of the progenitor cell compartment that includes normal LTC-IC. that were analyzed for chromosomal abnormalities by FISH were exclusively normal in assays of cells from patients 2,
In most cases FISH analysis of CFC plated directly into methylcellulose assays from patient BM or PB samples, or 3, 4, 6, and 8. However, in assays of cells from LTC of samples from patients 1 and 7, 7 of 23 and 1 of 6 BFU-E, CFC from 5-week-old LTC showed a mixture of cytogenetically normal and abnormal cells. In some cases the apparrespectively, were cytogenetically abnormal. ently high proportion of ''normal'' CFC may have been DISCUSSION related to the probe that was chosen for FISH analysis, eg, the Y probe was selected for detection of cytogenetically The malignancies encompassed under the term AML exabnormal CFC from patients 1 and 2 at a time when reliable hibit considerable heterogeneity in many aspects of their FISH probes for the inv(16) and t(8;21) were not available. pathological features and clinical behavior. As shown by the It is possible that malignant CFC with the inversion or transdata presented here (Tables 3, 4 , and 5) and from a variety location but retaining the Y chromosome were present but of other laboratories, 6-8,20,21 one aspect of this heterogeneity is scored as normal by FISH. Similarly, the absence of the the variability with which leukemic cells from AML patients /8/8 abnormality from all colonies analyzed from both respond to different cytokines. However, the majority of direct methylcellulose assays and LTC of cells from patient leukemic blast cells and AML-CFC exhibit some degree of 9 was surprising given the high PB blast cell count and the responsiveness to conditions that stimulate the growth of morphology of the colonies analyzed, which was typical of normal hematopoietic cells in vitro. This suggested that a AML-CFC. It seems likely that at least some of these colomore primitive type of AML precursor cell analogous to nies were in fact malignant although cytogenetically normal normal LTC-IC might also be supported by conditions develby FISH, a possibility that has also been suggested by othoped for normal progenitors, as shown for Ph chromosome ers. 34 Thus, the percentages of cytogenetically abnormal CFC positive LTC-IC present in the PB and BM of patients with detected by FISH (shown in Tables 6 and 7) are minimal CML. 13, 14 estimates of the proportion of AML progenitors present in The existence of a hierarchy of malignant progenitors these cultures. Nevertheless, it seems likely that residual in AML that might include LTC-IC had been previously normal hematopoietic cells coexist with AML progenitors suggested by the ability of some AML progenitors to undergo self-renewal to generate AML-CFC in suspension culin many of these samples. The fact that all erythroid colonies
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From examined from five of seven patients were normal by FISH both the sensitivity of the assay conditions and, in cultures containing a mixture of normal and malignant cells, their supports this possibility. Normal LTC-IC circulate in the PB at easily detectable frequencies. 18 Thus, it is not surprising relative frequency. Thus, under conditions where AML LTC-IC are relatively rare in the input population, as compared that they could be found in cultures from patients 8 and 10 because in these the peripheral white blood cell count and with normal LTC-IC, their recognition may be difficult unless culture conditions are optimal. The use of preestablished the proportion of blasts were relatively low, and the FISH probe for inv (16) would be expected to discriminate reliably feeders in LTC and recombinant cytokines in methylcellulose assay has improved the LTC-IC assay since the original between normal and malignant CFC (Fig 1) . However, as shown on Table 8 , the concentration of cytogenetically nor-AML LTC were performed allowing malignant LTC-IC to be observed even in the presence of residual normal hematomal LTC-IC in the PB of these AML patients was 10-to 100-fold higher than the concentration of LTC-IC we have poiesis. However, if the detection of normal LTC-IC is substantially favored, as it appears to be in some cases when previously observed in the blood of normal individuals. This suggests the possibility that normal LTC-IC can be mobimixed feeders are used, AML LTC-IC can still be difficult to detect. The detection of AML LTC-IC is also made more lized into the PB as part of the leukemic process.
Some differences were observed between the behaviour difficult by their low output of CFC progeny as compared with normal LTC-IC under current assay conditions. A final of AML progenitors in LTC and their normal counterparts characterized previously. Firstly, although Sl/Sl fibroblast possibility that would explain the reduced production of AML-CFC in previous LTC experiments, which is not adfeeders are equivalent to HMF for the support of normal LTC-IC, 23 they did not allow the detection of AML LTCdressed by the current experiments but is suggested by the results of studies in CML, 14 is that the standard LTC condi-IC from patient samples 2, 5, and 7 as well as HMF. Nevertheless, when IL-3 and SF or FL were added these patient cell tions previously tested may favor the self-maintenance of normal LTC-IC whereas at least some of the conditions samples showed an increase in the output of cytogenetically abnormal CFC to levels at least as high as those obtained tested in the current experiments may provide more equivalent support for primitive normal and malignant progenitors. with HMF, suggesting that these AML LTC-IC were particularly responsive to one or more of these cytokines and largely
In conclusion, these experiments have shown the existence of a rare progenitor among the leukemic cells of patients failed to produce AML-CFC progeny in their absence.
With four of the AML samples, growth factor supplements with AML, which will initiate long-term hematopoiesis in cocultures containing fibroblast feeder layers that support to LTC, either as biweekly factor additions or with the use of feeders engineered to produce human cytokines, reduced normal LTC-IC. These conditions allow such AML LTC-IC to be quantitated and characterized. Manipulation of the the proportion of cytogenetically abnormal CFC detected in 5-week-old cultures. In cultures of cells from patients 3, 8, cytokine conditions present in LTC was shown to affect AML LTC-IC or their immediate progeny differently from and 10, the predominant effect was the stimulation of normal CFC output by mixed feeders. This finding was not unexcoexisting normal LTC-IC. Further exploitation of this system should allow other factors important to the regulation pected as we have previously shown that these feeders producing IL-3, SF, and G-CSF enhance normal CFC output of primitive AML progenitors to be elucidated. from LTC up to 20-fold as compared with control feeders. It is therefore of interest that AML LTC-IC failed to show
